THORVACS aims to provide high quality experimental services to researchers in our country and around the world with its R&D laboratory infrastructure in Bilkent Cyberpark.
With the R&D projects it carries out, it aims to develop highly effective, new generation vaccine adjuvants against diseases that threaten animal and human health, diagnostic kits to be used in the diagnosis of these diseases, and various high quality products for research purposes used in laboratories.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Üniversiteler Mah. Bilkent Cyberpark A-Blok No:607, 06800 Çankaya, Ankara,06800,turkey
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.thorvacs.com/
- HQ
- Ankara
Thorvacs Biotechnology Questions
Thorvacs Biotechnology's website is https://www.thorvacs.com/
Thorvacs Biotechnology's LinkedIn profile is https://tr.linkedin.com/company/thorvacs
Thorvacs Biotechnology has
4 employees.
View email and phone details for 4
employees at Thorvacs Biotechnology.
Thorvacs Biotechnology's industry is
Biotechnology Research
Thorvacs Biotechnology's top competitors are
Gen Plaza Biyoteknoloji Merkezi,
Barbiotech Biyoteknoloji Enerji Savunma A.ş.,
Mikroliz Biyoteknoloji,
Polgen Biyoteknoloji,
Greentech Biotechnology,
Synbiotik Biotechnology,
Hücrecell® Biotechnology, Inc.,
Onima Biyoteknoloji,
Biocule Biyoteknoloji,
Porion Biyoteknoloji.
Thorvacs Biotechnology's categories are Biotechnology Research
Thorvacs Biotechnology's founding year is 2013
